Wildman Daniel George — SEC Form 4 filings

SEC reporting owner CIK 1952679. 4 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-08-08 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
UroGen Pharma Ltd. (URGN)Director47

Form 4 filings — Wildman Daniel George

FiledFormIssuerReported transactionsSource
2026-06-244UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2025-12-014UroGen Pharma Ltd. (URGN)Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2025-08-274UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2024-08-084UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1952679 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →